FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Teleflex Q1 Beats Expectations, Advances Portfolio Transformation

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Teleflex delivered Q1 2026 results with revenue of $548.3M (+32.3% Y/Y), $11M above the consensus, though pro forma adjusted constant currency growth of 5.1% reflects underlying momentum. Adjusted EPS of $1.39 met the consensus but declined from $1.44 the prior year, with significant margin compression as adjusted gross margin fell 470 bps to 61.4% due to tariffs, quality charges, and BIOTRONIK integration. Portfolio transformation shows mixed segment results, with Surgical leading at 9.9% pro forma growth while Interventional faced integration challenges at 3.0% growth. Management maintained full-year 2026 adjusted EPS guidance of $6.25-$6.55, incorporating $90M in stranded costs from divestitures. The company announced a new CEO, Jason Weidman, effective June 8, bringing 25+ years medical device experience as the company focuses on its portfolio optimization plans. We expect the $90M stranded costs fully offset by transition services beginning 2027, providing clearer standalone financial visibility.

Related Articles

Mining & Metals

RBC Maintains Suncor Energy's Outperform Rating, C$100 Price Target

RBC Capital Markets on Wednesday reiterated Suncor Energy's (SU.TO) outperform rating and C$100 price target, with the bank noting the company delivered another quarter of "robust performance" punctuated by a "jumbo-sized" downstream pre-tax margin of $2 billion (including FIFO gains) in part driven by record refined product sales of 680,900 bbl/d.RBC's updated production outlook of 862,100 bbl/d, anchored by a $5.7 billion capital program, remains relatively unchanged."Suncor's first-quarter results reinforced our confidence that its culture of sustained high performance is taking deep root and enabling the company to be on the podium, come what may," RBC said. "We believe the ingredients are in place for the company to earn a premium relative valuation, conceivably over the next year," RBC added.Suncor is RBC's favorite integrated producer in Canada and is part of its Global Energy Best Ideas list.Suncor traded at $85.70 per share at last look Thursday on the Toronto Stock Exchange.Price: $85.70, Change: $-2.21, Percent Change: -2.51%

$SU.TO
Australia

RBC Capital Adjusts VSE Price Target to $240 From $220, Maintains Outperform Rating

VSE (VSEC) has an average rating of Buy and mean price target of $248.50, according to analysts polled by FactSet.Price: $206.85, Change: $-0.60, Percent Change: -0.29%

$VSEC
Australia

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

United Therapeutics (UTHR) has an average rating of buy and mean price target of $670.67, according to analysts polled by FactSet.Price: $585.63, Change: $-11.14, Percent Change: -1.87%

$UTHR